We also identified, through the establishment of specific cut-offs, a subset of patients at higher risk of MAS (patients with ferritin more than 1225 ng/ml) and AOSD-related mortality (patients with CRP levels more than 68.7 mg/L). This evidence concerns the gene CRP and macrophage activation syndrome.